Coronavirus disease 2019 (COVID-19) is the third coronavirus outbreak that has emerged in the past 20 years, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). One important aspect, highlighted by many global health organizations, is that this novel coronavirus outbreak may be especially hazardous to healthcare personnel, including laboratory professionals. Therefore, the aim of this document, prepared by the COVID-19 taskforce of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is to provide a set of recommendations, adapted from official documents of international and national health agencies, on biosafety measures for routine clinical chemistry laboratories that operate at biosafety levels 1 (BSL-1; work with agents posing minimal threat to laboratory workers) and 2 (BSL-2; work with agents associated with human disease which pose moderate hazard). We believe that the interim measures proposed in this document for best practice will help minimazing the risk of developing COVID-19 while working in clinical laboratories.
Keywords: COVID-19; SARS-COV-2; biosafety; coronavirus disease 2019; laboratory.
Features, Evaluation and Treatment Coronavirus (COVID-19).2020 Apr 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. StatPearls. 2020 Jan–. PMID: 32150360 Free Books & Documents. Review.
Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis.Indian J Med Res. 2020 Feb & Mar;151(2 & 3):172-176. doi: 10.4103/ijmr.IJMR_763_20. Indian J Med Res. 2020. PMID: 32242878 Review.
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence.Clin Chem Lab Med. 2020 May 27:/j/cclm.ahead-of-print/cclm-2020-0722/cclm-2020-0722.xml. doi: 10.1515/cclm-2020-0722. Online ahead of print. Clin Chem Lab Med. 2020. PMID: 32459192 Review.
The Coronavirus Pandemic: What Does the Evidence Show?J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596. J Nepal Health Res Counc. 2020. PMID: 32335585 Review.
Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).Clin Exp Pediatr. 2020 Apr;63(4):119-124. doi: 10.3345/cep.2020.00493. Epub 2020 Apr 2. Clin Exp Pediatr. 2020. PMID: 32252141 Free PMC article.
Cited by 1 article
Neurological manifestations associated with COVID-19: a review and a call for action.J Neurol. 2020 May 20:1-4. doi: 10.1007/s00415-020-09896-z. Online ahead of print. J Neurol. 2020. PMID: 32436101 Free PMC article. Review.